13 May 2025 Date | | - Cons. EPS | - EPS |
12 Nov 2024 Date | | - Cons. EPS | - EPS |
16 Aug 2024 Date | | - Cons. EPS | - EPS |
14 Aug 2024 Date | | - Cons. EPS | - EPS |
13 Aug 2024 Date | | - Cons. EPS | - EPS |
13 May 2025 Date | | - Cons. EPS | - EPS |
12 Nov 2024 Date | | - Cons. EPS | - EPS |
16 Aug 2024 Date | | - Cons. EPS | - EPS |
14 Aug 2024 Date | | - Cons. EPS | - EPS |
13 Aug 2024 Date | | - Cons. EPS | - EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Bradley J. Yourist CEO | OTC PINK Exchange | 388598104 Cusip |
US Country | 9 Employees | - Last Dividend | 16 Mar 2018 Last Split | - IPO Date |
Grapefruit USA, Inc. is a company specialized in the manufacturing and distribution of cannabis products within the state of California. Originally known as Grapefruit Boulevard Investments, Inc., the company underwent a name change in January 2020 to better reflect its identity and mission. Founded in 2017 and based out of Wilmington, Delaware, Grapefruit USA, Inc. has made a significant impact in the cannabis industry by providing innovative products and services. The company's operations are tailored toward leveraging the medicinal and recreational benefits of cannabis through their unique product offerings.